Journal Logo

Original Clinical Science—General

Intensive Care to Facilitate Organ Donation: A Report on the Experience of 2 Spanish Centers With a Common Protocol

Martínez-Soba, Fernando MD1; Pérez-Villares, José M. MD, PhD2; Martínez-Camarero, Lidia MD1; Lara, Ramón MD2; Monzón, José L. MD, PhD3; Fernández-Carmona, Alberto MD2; Marco, Pedro MD4; Coll, Elisabeth MD, PhD5; Domínguez-Gil, Beatriz MD, PhD5

Author Information
doi: 10.1097/TP.0000000000002294
  • Free

Abstract

Organ transplantation is one of the greatest achievements of modern medicine, which full expansion is limited by the shortage of organs to cope with the transplantation needs of patients.1 The decrease in the incidence of events that lead to devastating brain injury (DBI) and improvements in neurocritical care are determining a decline in mortality relevant to organ donation2 and in the incidence of brain death (BD)3 in developed countries. It is hence imperative to look for alternative ways of increasing organ availability.

Several critical care societies support the concept that donation should be an integral component of end-of-life care.4-8 This concept is embedded in the progressively more accepted principle that decision making at the end-of-life should be based, not only on clinical criteria, but also on moral, societal, and welfare considerations.9 Therefore, offering the option of organ donation can be seen as a duty of professionals responsible for the care of patients who could be possible organ donors from the perspective of patients they care for.

The Spanish Society of Intensive Care Medicine and Coronary Units and the Spanish National Transplant Organization have recently released national recommendations on Intensive Care to facilitate Organ Donation (ICOD). ICOD is defined as the initiation or continuation of intensive care measures in patients with a DBI in whom medical or surgical treatment for curative purposes is deemed futile, and who are considered possible organ donors, with the aim of incorporating the option of donation after brain death (DBD) into their end-of-life care plans.

In Spain, ICOD is supported by the legal and ethical framework and professional codes of practice.6-8,10-14 ICOD, in the form of continuing intensive care beyond futility to enable organ donation, is also a reality in other countries.15-17 On the contrary, elective nontherapeutic ventilation (ENTV) is a rare practice. Most publications available on ICOD have exclusively focused on its ethical, legal, and philosophical aspects.18-31 Only a Spanish study has recently provided a broad overview of the implementation of ICOD, also describing its associated challenges.32 However, a major limitation of this study was that it only focused on patients who had actually died as a result of a DBI and in whom the option of ICOD had been discussed with their families. It hence failed to focus on all patients in whom ICOD had been considered, regardless of their final outcome—death, undesirable neurological states, or clinical improvement. The possibility that patients are subject to ICOD and later they experience unexpected outcomes is possibly one of the most important concerns about this practice. A second limitation of the said study was that it had not been designed to identify best practices in ICOD.

In 2006, the donor coordination unit at the Hospital San Pedro (La Rioja) conceived a dedicated protocol on ICOD, which was subsequently adopted by the Hospital Universitario Virgen de las Nieves (Granada) in 2011. The aim of this manuscript is to describe the experience with ICOD at these two hospitals under a common protocol, with a focus on all patients in whom this option has been posed, regardless of their final outcome, and to evaluate the impact of ICOD on organ donation and transplantation activities.

PATIENTS AND METHODS

Terminology

Terms relevant to this article are summarized in Table 1.

TABLE 1.
TABLE 1.:
Terminology relevant to this study taken from SEMICYUC-ONT Recommendations on ICOD

Hospital Description

Hospital San Pedro serves a population of 315 000 inhabitants and counts on 503 beds, including 17 intensive care unit (ICU) beds. It has a neurology, but not a neurosurgery service. Hospital Universitario Virgen de las Nieves serves 915 000 inhabitants and counts on 944 beds. The ICU has 48 beds, including 12 for neurocritical patients. The hospital has neurosurgery and neurology services. Both hospitals have donor coordination teams composed of ICU physicians and nurses.

Protocol for ICOD

a) Systematic referral of patients with a DBI to the donor coordinator

Patients with a DBI (Glasgow Coma Scale [GCS] <9, in the absence of sedation and other confounding factors) are referred to the donor coordinator (DC) once the treating team has decided that further medical or surgical treatment with a curative purpose will not be attempted based on futility. The DC does not participate of this decision, which is made by an independent multidisciplinary team. Referral occurs whether the patient is being treated at the ICU, the emergency room, or a hospital ward, and whether the patient is invasively ventilated or not.

b) Strict selection criteria of patients with a DBI as possible donors

The DC only considers the possibility of ICOD if:

  • ▪BD is a likely outcome within a short period. The likelihood of BD is evaluated based on clinical criteria (GCS and brain stem reflexes assessed under the appropriate clinical conditions) and signs of intracranial hypertension and herniation in the CT scan.
  • ▪There are no apparent medical contraindications to donation, based on information available on the clinical chart and obtained from the relatives.

c) Assessment of the patient’s wishes about organ donation

The DC checks the Advanced Directives Registry.11-14 The protocol does not proceed if the patient has registered his opposition to posthumous donation. If the patient has registered their will to donate, this information is shared with their family. If no registration exists, information is gathered from the family on whether organ donation was consistent with the patient’s wishes and values.

d) Informed consent for ICOD

The interview to discuss organ donation and ICOD (early interview) is framed under a continuous information process. First, the treating team informs the family of the patient’s ominous prognosis and the decision that further therapeutic measures will not be attempted and care will shift to palliative and end-of-life care. The early interview, which is always led by the DC, is only initiated after verifying that the relatives have understood and accepted the situation and have the capacity to make decisions. The moment to initiate this early interview and the pace in the provision of information is always determined by the emotional status of the family. The so-called anticipated grief is managed through an aid relationship, where respect, empathy, and authenticity are the pillars of communication.

If unknown, the DC explores the wishes of the patient during the interview. If the patient and the family are favorable toward donation, the DC explains: (i) the measures required to ensure the preservation of organs until BD, stressing that there is no therapeutic aim and that the comfort of the patient will be paramount; (ii) that BD usually occurs within 24 to 72 hours,32,33 but it may take longer or even not occur; (iii) that the patient may finally not be a suitable organ donor.

The DC agrees with the family on a maximum observation period and the plan, should BD not occur or relatives wish to revoke consent.

e) Specific management of possible organ donors within the ICU

The comfort of the patient during the dying process is paramount—analgesia is provided with sedatives when required. Measures to ensure the preservation of potentially transplantable organs are initiated/continued, inclusive of admission to the ICU, respiratory, and hemodynamic support. Other futile interventions are avoided. The DC must complete the evaluation of donor/organ suitability. Once BD occurs, consent for organ recovery is obtained. If the patient does not evolve to BD within the time agreed with the relatives or if the family revokes consent, measures are reoriented to only ensure the comfort of the patient and to end-of-life care.

Study Design and Data Analysis

This is a retrospective observational study. The investigators reviewed the clinical chart of patients with a DBI in whom further treatment was deemed futile, who were selected as possible organ donors by the DC, and in whom an interview with the family was held to discuss the option of ICOD during the period extending from January 1, 2011, to December 31, 2015.

Demographic and clinical data of the patient population are described. To represent the severity of the brain injury, the GCS, the intracerebral hemorrhage score,34 the Ischemic Stroke Predictive Risk Score, and the World Federation of Neurological Surgeons scale35 have been used. The circumstances of the family approach, the frequency of consent to ICOD, the clinical outcome of patients subject to ICOD, and the deceased donation pathway are described.

Qualitative variables are represented by absolute numbers and percentages. Quantitative variables are presented as mean and standard deviation. The analysis has been performed with the statistical package, SPSS 25.0.

The study was approved by the institutional review board of both centers.

RESULTS

The option of ICOD was discussed with the families of 131 patients with a DBI in whom further treatment had been deemed futile by the treating team, BD was a likely outcome, and had no apparent medical contraindications to organ donation.

The demographics and clinical characteristics of patients are shown in Table 2.

TABLE 2.
TABLE 2.:
Demographics and clinical characteristics of patients whose family was approached to pose the option of intensive care to facilitate organ donation

The interview with the relatives was most frequently held in the emergency room (87; 66%), followed by the neurology ward (24; 18%), the ICU (17; 13%), the neurosurgery ward (2; 2%), and the anesthesia unit (1; 1%). The conversation took place when the decision had been made not to intubate/ventilate the patient with a therapeutic purpose in 66 (50%) patients and when the decision had been made not to continue with the already initiated invasive ventilation in the remaining 65. The time between hospital admission and the interview was less than 24 hours in 107 (82%) cases.

The donation pathway is summarized in Figure 1.

FIGURE 1.
FIGURE 1.:
Deceased donation pathway from patients whose families were approached to pose the option of intensive care to facilitate organ donation. ICOD, Intensive Care to facilitate Organ Donation; WLST, withdrawal of life-sustaining therapy.

Consent for ICOD was obtained in 125 (95%) cases. The 6 patients without consent for ICOD were all not intubated/ventilated at the time of the early interview.

ICOD was initiated in all 125 consented cases, inclusive of 60 patients who were subject to ENTV.

All patients with consent for ICOD died: 101 (81%) evolved to BD, 18 (14%) died after the decision to withdraw life-sustaining treatment (WLST) and 6 (5%) after an unexpected cardiac arrest. The reason for the WLST was medical unsuitability to organ donation identified after ICOD had been initiated in 4 cases and exceeded time of observation agreed with the family and/or family decision in the remaining 14 patients. Donation after circulatory death was not considered in any of these patients, although only 1 was younger than 70 years.

Ninety-nine (98%) patients transitioned to actual DBD. The reason why 2 brain-dead patients were not converted into actual organ donors were medical contraindications to organ donation.

Seventy-nine (80%) actual donors were converted into utilized DBD donors, with 49 kidneys, 62 livers, 5 lungs, 2 hearts, and 1 pancreas transplanted. This represented 1.2 organs transplanted per actual donor, and 1.5 organs transplanted per utilized donor.

ICOD contributed to 33% of actual donation activity in both hospitals during the study period, with variations between the 2 hospitals (Figure 2).

FIGURE 2.
FIGURE 2.:
Actual organ donors by ICOD in participating hospitals. Years 2011 to 2015. ICOD, Intensive Care to facilitate Organ Donation.

All patients with an early interview for ICOD died. Time until death for patients for whom consent was obtained for ICOD is represented in Table 3.

TABLE 3.
TABLE 3.:
Time between the early interview and death for patients subject to intensive care to facilitate organ donation

DISCUSSION

The Royal Devon and Exeter Hospital was the first to publish the concept of ENTV to refer to the ventilation of patients with a DBI at risk of imminent death with the purpose of enabling evolution to BD and organ donation.36 In Spain, the term ICOD is preferred to stress that care for the dying patient remains paramount and to clarify that measures, other than ENTV, are required to enable organ donation in this context.32

ENTV was heavily criticized during the 1990s and abandoned in the United Kingdom under the doubt of its legality.37 The debate has been served since then, but with a conversion into a progressively more favorable attitude toward the practice.18,23-31 Scholars have debated about the risk of harming possible donors and their families for the benefit of others.19,20 On the other hand, the emerging concept that donation should be an integral component of end-of-life care4,5,7,8 makes not considering organ donation in a dying patient an approach not respectful with the fundamental principle of autonomy. Decision making at the end-of-life should take account of the wishes and beliefs of the individual.

In Spain, ICOD is properly grounded on the legal, deontological, and ethical framework, because it respects the patient’s dignity and allows professionals to comply with their duties toward patients and their families.6-8,10-14 Although the practice of continuing intensive care to enable the determination of death by neurological criteria and DBD is routine practice in some countries,15-17 this is not the case in many others, particularly when the decision to withdraw care is made outside of the ICU.15,38 Moreover, ENTV still raises debates in the international fora.

In this context, we aimed at sharing our experience with ICOD by describing the practice as a stepwise process in a manner that allows to understand the reality of its associated challenges: predicting the likelihood of BD, assessing donor/organ suitability with limited information available, informing relatives, and using scarce ICU resources for the care of a dying patient.32 To our knowledge, this is the first report on ICOD that focuses on all patients whose families were approached to pose this option and with a commonly applied protocol. Key elements of this protocol are detailed below.

Strict Criteria for the Selection of Patients With a DBI as Possible Organ Donors

ICOD is only considered if prognosis is deemed ominous and the decision has been made not to treat by a multidisciplinary team independent from the DC. The severity of the brain injury was extreme in our study, as made evident by the prognostic scores at the moment of the early interview. Although ischemic stroke is more frequent than hemorrhagic stroke in our setting, the assessment of prognosis is more accurate in the latest. This likely justifies that the majority of patients included in our protocol had been diagnosed with a hemorrhagic stroke. The assessment of prognosis was quite precise in our experience: all patients subject to ICOD died during their ICU stay and 81% evolved to BD within a short time, as predicted. Other studies support that evolution to BD in patients with a DBI occurs shortly.22,32,39 Importantly, no case was reported of improvement, and no patient evolved to an unfavorable neurological state.

Only patients with no apparent medical contraindications to donate were included in the protocol. The assessment of medical suitability of these patients as possible organ donors is complex given their advanced age—as a mean, 75 years in our series. The selection performed was appropriate, because only rarely were medical contraindications identified after having initiated ICOD.

Comprehensive and Transparent Information to the Family

The early interview should pursue that decisions by the family are made after receiving complete information. It should focus in understanding whether organ donation was consistent with the patient’s wishes and values. Information must also include prognostic and other uncertainties—that BD may take longer than 24 to 72 hours or may not occur, and that medical contraindications may arise later in the process. It is critical to agree on an observation period and inform of the way to proceed if BD does not occur. The family must be informed of the measures required to enable organ donation. According to the Spanish legislation, the family must grant authorization for specific interventions if patients lack capacity.12,13 Hence, specific authorization is required for ICOD. Family care during the entire process is paramount.

Despite the difficulty of the early interview, authorization for ICOD was extraordinarily high in our experience (95%), especially considering the high percentage of nonintubated patients (50%), and that 87% of the interviews took place outside of the ICU shortly after hospital admission. This consent rate is higher than that described in Spain for conventional donation interviews, once the patient has developed a BD condition (80%–85%).39 We are convinced that the training and experience of professionals involved in this difficult type of interview have been critical to this impressive result.

Specific Management of the Possible Donor Within the ICU

The key aspect during the admission of possible donors in the ICU is ensuring the comfort of the patient. Only those interventions required for the preservation of transplantable organs should be undertaken, disregarding any other futile measures.

The use of ICU resources for patients who would not be admitted in the ICU under other circumstances is a major concern when considering the implementation of an ICOD protocol. The proper selection of cases is fundamental. The resulting short ICU stay in our series seems appropriate given the benefits of transplantation and the cost-effectiveness of kidney transplants. A recent Australian study estimated that admitting patients in the ICU for palliative care and organ donation confers the community with 7.3 quality adjusted life year per ICU bed day.40

In our series, 79% of patients subject to ICOD transitioned to actual donation. During the study period, 33% of actual donors at both hospitals derived from ICOD, making them reach levels of donation per million population over 50 to 60, compared with national values below 40 for those years. Differences in the contribution of ICOD to actual donation at both hospitals likely relate to the type of center (only one a reference neurosurgical center) and the specific clinical pathway applied to the treatment of neurocritical patients.

Organs recovered were not always suitable for transplantation, which must be interpreted based on the very advanced age of possible donors in our series. Candidates to ICOD were in their 70s/80s. In Spain, the recovery of these organs is routine practice with the assumption that organ utilization is not as good as for young donors.41 However, and in total, the practice derived on 1.2 organs transplanted per actual donor and 1.5 per utilized donor. In implementing ICOD, it is essential that transplant centers are actively using organs from this advanced age donor groups.

CONCLUSIONS

Results of this ICOD protocol are encouraging; the prediction of BD was accurate, the practice was well accepted by families, the ICU stay was short, and the impact on donation rates high. This experience invites to revisit ICOD where this is not a reality yet. This will require overcoming the barriers generated by outdated legislations, uncertainties in the selection of possible donors, the limited capacity of our ICUs, the complexity in the communication with the family, and the difficulty to accept donation as an option that respects the autonomy of patients.

REFERENCES

1. WHO Collaborating Centre on Donation and Transplantation. Global Observatory on Organ Donation and Transplantation. Transplant Observatory website. Available at http://www.transplant-observatory.org/. Accessed March 2018.
2. Organisation for Economic Co-operation and Development. Health at a Glance. 2017. OECD Indicators website. Available at http://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm. Accessed March 2018.
3. De la Rosa G, Domínguez-Gil B, Matesanz R, et al. Continuously evaluating performance in deceased donation: the Spanish quality assurance program. Am J Transplant. 2012;12:2507–2513.
4. Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College of Critical Care Medicine. Crit Care Med. 2008;36:953–963.
5. Bossaert LL, Perkins GD, Askitopoulou H, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 11. The ethics of resuscitation and end-of-life decisions. Resuscitation. 2015;95:302–311.
6. Hernández-Tejedor A, Peñuelas O, Sirgo Rodríguez G, et al. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients. Med Intensiva. 2017;41:285–305.
7. Martínez Soba F, Masnou Burrallo N, de la Rosa Rodríguez G, et al. Emergency department staff and the organ donation process: recommendations from the joint working group of the National Transplant Organization and the Spanish Society of Emergency Medicine (ONT-SEMES). Emergencias. 2016;28:193–200.
8. Cabré, Pericas LL, Abizanda Camposb R, Baigorri, González F, et al. Code of ethics of the Spanish Society of Intensive Care, Critical and Coronary Units (SEMICYUC). Med Intensiva. 2006;30:68–73.
9. Committee on Bioethics (DH-BIO) of the Council of Europe. Guide on the decision-making process regarding medical treatment in end-of-life situations. Council of Europe website. Available at http://www.coe.int/en/web/bioethics/guide-on-the-decision-making-process-regarding-medical-treatment-in-end-of-life-situations. Accessed March 2018.
10. Código de deontología médica. Guía de ética médica. Organización Médica Colegial De España website. Available at http://www.cgcom.es/etica_edont. Accessed March 2018.
11. Real Decreto 1723/2012, de 28 de diciembre, por el que se regulan las actividades de obtención, utilización clínica y coordinación territorial de los órganos humanos destinados al trasplante y se establecen requisitos de calidad y seguridad. Página web Organización Nacional de Trasplantes. Available at http://www.ont.es/infesp/Legislacin/BOERD1723-2012.pdf. Accessed March 2018.
12. . Ley 41/2002, de 14 de noviembre, básica reguladora de la autonomía del paciente y de derechos y obligaciones en materia de información y documentación clínica. Available at https://www.boe.es/diario_boe/txt.php?id=BOE-A-2002-22188. Accessed March 2018.
13. . Ley 26/2015, de 28 de julio, de modificación del sistema de protección a la infancia y a la adolescencia. Available at https://www.boe.es/diario_boe/txt.php?id=BOE-A-2015-8470. Accessed March 2018.
14. . Real Decreto 124/2007, de 2 de febrero, por el que se regula el Registro nacional de instrucciones previas y el correspondiente fichero automatizado de datos de carácter personal. Available at https://www.boe.es/diario_boe/txt.php?id=BOE-A-2007-3160. Accessed March 2018.
15. Work Package 5—Increasing the collaboration between donor transplant coordinators and intensive care professionals. Final report. ACCORD Website. Available at http://www.accord-ja.eu/. Accessed March 2018.
16. Melville A, Kolt G, Anderson D, et al. Admission to intensive care for palliative care or potential organ donation: demographics, circumstances, outcomes, and resource use. Crit Care Med. 2017;45:e1050–e1059.
17. Nelson HM, Glazier AK, Delmonico FL. Changing patterns of organ donation: brain dead donors are not being lost by donation after circulatory death. Transplantation. 2016;100:446–450.
18. Shaw AB. Non-therapeutic (elective) ventilation of potential organ donors: the ethical basis for changing the law. J Med Ethics. 1996;22:72–77.
19. Browne A, Gillett G, Tweeddale M. The ethics of elective (non-therapeutic) ventilation. Bioethics. 2000;14:42–57.
20. Stammers T. ‘Elective’ ventilation: an unethical and harmful misnomer? New Bioeth. 2013;19:130–140.
21. Gillett G. Honouring the donor: in death and in life. J Med Ethics. 2013;39:149–152.
22. Wilkinson D. Ventilating the debate: elective ventilation revisited. J Med Ethics. 2013;39:127–128.
23. Emmerich N. Elective ventilation and the politics of death. J Med Ethics. 2013;39:153–157.
24. Savulescu J. Elective ventilation and interests. J Med Ethics. 2013;39:129.
25. Coggon J. Elective ventilation for organ donation: law, policy and public ethics. J Med Ethics. 2013;39:130–134.
26. Baumann A, Audibert G, Guibet Lafaye C, et al. Elective non-therapeutic intensive care and the four principles of medical ethics. J Med Ethics. 2013;39:139–142.
27. De Lora P, Blanco AP. Dignifying death and the morality of elective ventilation. J Med Ethics. 2013;39:145–148.
28. Frati P, Fineschi V, Gulino M, et al. Ethical and legal implications of elective ventilation and organ transplantation: “medicalization” of dying versus medical mission. Biomed Res Int. 2014;2014:973758.
29. Escudero D, Otero J. Medicina Intensiva y Donación de órganos: ¿explorando las últimas fronteras? Med Intensiva. 2015;39:366–374.
30. Camut S, Baumann A, Dubois V, et al. Non-therapeutic intensive care for organ donation: a healthcare professionals’ opinion survey. Nurs Ethics. 2016;23:191–202.
31. Escudero D, Otero J, Menéndez de León B, et al. Organ donation and elective ventilation: a necessary strategy. Biomed Res Int. 2017;2017:7518375.
32. Domínguez-Gil B, Coll E, Elizalde J, et al. Expanding the donor pool through intensive care to facilitate organ donation: results of a Spanish multicenter study. Transplantation. 2017;101:e265–e272.
33. Escudero D, Valentín MO, Escalante JL, et al. Intensive care practices in brain death diagnosis and organ donation. Anaesthesia. 2015;70:1130–1139..
34. Hemphill JC, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–897.
35. Drake CG, Hunt WE, Sano K, et al. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. 1988;68:985–986.
36. Feest TG, Riad HN, Collins CH, et al. Protocol for increasing organ donation after cerebrovascular deaths in a district general hospital. Lancet. 1990;335:1133–1135. [published erratum appears in Lancet 1990; 335: 1412].
37. Riad H, Nicholls A. Elective ventilation of potential organ donors. BMJ. 1995;310:714–718.
38. Witjes M, Kotsopoulos A, Herold IHF, et al. The influence of end-of-life care on organ donor potential. Am J Transplant. 2017;17:1922–1927.
39. Domínguez-Gil B, Coll E, Pont T, et al. End-of-life practices in patients with devastating brain injury in Spain: implications for organ donation. Med Intensiva. 2017;41:162–173.
40. Nunnink L, Cook DA. Palliative ICU beds for potential organ donors: an effective use of resources based on quality-adjusted life-years gained. Crit Care Resusc. 2016;18:37–42.
41. Matesanz R, Domínguez-Gil B, Coll E, et al. How Spain reached 40 deceased organ donors per million population. Am J Transplant. 2017;17:1447–1454.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.